Immunotherapy in advanced esophageal squamous cell cancer: earlier or later?

Immunotherapy in advanced esophageal squamous cell cancer: earlier or later?

Background and objectiveSeveral large-scale phase III clinical trials have confirmed the survival benefit of immunotherapy in patients with locally advanced or metastatic esophageal cancer (EC). The study aimed to investigate whether early use of immunotherapy can improve long-term survival.MethodsP...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuang Wei, Zuoji Li, Tingting Liu, Guizhen Sun, Hongfu Sun, Wei Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
immunotherapy
esophageal squamous cell cancer
overall survival
EIT
LiT
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1524176/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items